For more than 30 years, PAP therapy has focused on increasing inspiratory pressure and reducing expiratory pressure in hopes of improving comfort and adherence. Emerging evidence suggests this long-standing approach may have unintended consequences, including increased leak, pressure intolerance, and treatment-emergent central sleep apnea. This session explores a new direction in PAP therapy grounded in airway physiology and supported by recent clinical research. Tony Ross will walk attendees through the science behind reducing inspiratory pressure, the development of V̇-Com® as a proof-of-concept, and how Kricket™ (powered by KPAP™) delivers synchronized airway pressure that more closely mirrors natural breathing while maintaining therapeutic efficacy. Participants will leave with a clearer understanding of why pressure timing matters, how KPAP™ differs from conventional CPAP and bilevel approaches, and how these insights may improve patient experience and clinical outcomes in OSA therapy.